You just read:

Inhibikase Therapeutics, Inc. Receives FDA Clearance To Initiate Clinical Trials For Potential Disease-Modifying Therapies To Treat Parkinson's Disease

News provided by

Inhibikase Therapeutics, Inc.

Sep 14, 2016, 07:00 ET